748 related articles for article (PubMed ID: 26306594)
1. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F
Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistance.
Ewen S; Cremers B; Meyer MR; Donazzan L; Kindermann I; Ukena C; Helfer AG; Maurer HH; Laufs U; Grassi G; Böhm M; Mahfoud F
J Hypertens; 2015 Dec; 33(12):2519-25. PubMed ID: 26485463
[TBL] [Abstract][Full Text] [Related]
3. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G;
Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780
[TBL] [Abstract][Full Text] [Related]
4. The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence.
Ott C; Mahfoud F; Schmid A; Ewen S; Toennes SW; Meyer MR; Helfer AG; Maurer HH; Ditting T; Veelken R; Zivanovic I; Uder M; Böhm M; Schmieder RE
J Hypertens; 2016 Dec; 34(12):2475-2479. PubMed ID: 27607458
[TBL] [Abstract][Full Text] [Related]
5. Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.
Schmieder RE; Ott C; Schmid A; Friedrich S; Kistner I; Ditting T; Veelken R; Uder M; Toennes SW
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873693
[TBL] [Abstract][Full Text] [Related]
6. Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation.
Patel P; Gupta PK; White CM; Stanley AG; Williams B; Tomaszewski M
J Hum Hypertens; 2016 Jun; 30(6):368-73. PubMed ID: 26446393
[TBL] [Abstract][Full Text] [Related]
7. Impact of drug adherence on blood pressure response to alcohol-mediated renal denervation.
Persu A; Maes F; Toennes SW; Ritscher S; Georges C; Wallemacq P; Haratani N; Parise H; Fischell TA; Lauder L; Mahfoud F
Blood Press; 2022 Dec; 31(1):109-117. PubMed ID: 35575248
[TBL] [Abstract][Full Text] [Related]
8. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
[TBL] [Abstract][Full Text] [Related]
9. Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension.
Völz S; Andersson B; Manhem K; Haraldsson I; Rundqvist B
Blood Press; 2014 Aug; 23(4):228-32. PubMed ID: 24432803
[TBL] [Abstract][Full Text] [Related]
10. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
Bhatt DL; Vaduganathan M; Kandzari DE; Leon MB; Rocha-Singh K; Townsend RR; Katzen BT; Oparil S; Brar S; DeBruin V; Fahy M; Bakris GL;
Lancet; 2022 Oct; 400(10361):1405-1416. PubMed ID: 36130612
[TBL] [Abstract][Full Text] [Related]
12. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.
Kandzari DE; Böhm M; Mahfoud F; Townsend RR; Weber MA; Pocock S; Tsioufis K; Tousoulis D; Choi JW; East C; Brar S; Cohen SA; Fahy M; Pilcher G; Kario K;
Lancet; 2018 Jun; 391(10137):2346-2355. PubMed ID: 29803589
[TBL] [Abstract][Full Text] [Related]
13. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
[TBL] [Abstract][Full Text] [Related]
14. Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study.
Verheye S; Ormiston J; Bergmann MW; Sievert H; Schwindt A; Werner N; Vogel B; Colombo A
EuroIntervention; 2015 Feb; 10(10):1221-9. PubMed ID: 25452198
[TBL] [Abstract][Full Text] [Related]
15. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ
Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
[TBL] [Abstract][Full Text] [Related]
16. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
[TBL] [Abstract][Full Text] [Related]
17. Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension.
Pöss J; Ewen S; Schmieder RE; Muhler S; Vonend O; Ott C; Linz D; Geisel J; Rump LC; Schlaich M; Böhm M; Mahfoud F
Clin Res Cardiol; 2015 Aug; 104(8):672-8. PubMed ID: 25715938
[TBL] [Abstract][Full Text] [Related]
18. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
Lambert T; Gammer V; Nahler A; Blessberger H; Kammler J; Grund M; Kerschner K; Buchmayr G; Saleh K; Kypta A; Hönig S; Wichert-Schmitt B; Schwarz S; Sihorsch K; Reiter C; Steinwender C
Int J Cardiol; 2015 Feb; 181():96-101. PubMed ID: 25497527
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
Ziegler AK; Bertog S; Kaltenbach B; Id D; Franke J; Hofmann I; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010
[TBL] [Abstract][Full Text] [Related]
20. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.
; Esler MD; Krum H; Sobotka PA; Schlaich MP; Schmieder RE; Böhm M
Lancet; 2010 Dec; 376(9756):1903-9. PubMed ID: 21093036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
